Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx

<p>Microplastics (MPs) are increasingly implicated in cancer biology through effects on gene expression, stress responses, and treatment susceptibility; however, causal links remain provisional. We systematically screened PubMed and Google Scholar (through September 2025) to identify cancer-re...

Ամբողջական նկարագրություն

Պահպանված է:
Մատենագիտական մանրամասներ
Հիմնական հեղինակ: Akmaral Baspakova (17961710) (author)
Այլ հեղինակներ: Afshin Zare (18096433) (author), Nadiar M. Mussin (17961716) (author), Nader Tanideh (10439793) (author), Kulyash R. Zhilisbayeva (17961731) (author), Ramazon Safarzoda Sharoffidin (22629836) (author), Roza Suleimenova (22518749) (author), Gulden Yelgondina (22518752) (author), Akmeiir E. Kaliyeva (22679270) (author), Aigerim A. Umbetova (17961734) (author), Ainur Zinaliyeva (22679273) (author), Amin Tamadon (6313595) (author)
Հրապարակվել է: 2025
Խորագրեր:
Ցուցիչներ: Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
_version_ 1849927636000702464
author Akmaral Baspakova (17961710)
author2 Afshin Zare (18096433)
Nadiar M. Mussin (17961716)
Nader Tanideh (10439793)
Kulyash R. Zhilisbayeva (17961731)
Ramazon Safarzoda Sharoffidin (22629836)
Roza Suleimenova (22518749)
Gulden Yelgondina (22518752)
Akmeiir E. Kaliyeva (22679270)
Aigerim A. Umbetova (17961734)
Ainur Zinaliyeva (22679273)
Amin Tamadon (6313595)
author2_role author
author
author
author
author
author
author
author
author
author
author
author_facet Akmaral Baspakova (17961710)
Afshin Zare (18096433)
Nadiar M. Mussin (17961716)
Nader Tanideh (10439793)
Kulyash R. Zhilisbayeva (17961731)
Ramazon Safarzoda Sharoffidin (22629836)
Roza Suleimenova (22518749)
Gulden Yelgondina (22518752)
Akmeiir E. Kaliyeva (22679270)
Aigerim A. Umbetova (17961734)
Ainur Zinaliyeva (22679273)
Amin Tamadon (6313595)
author_role author
dc.creator.none.fl_str_mv Akmaral Baspakova (17961710)
Afshin Zare (18096433)
Nadiar M. Mussin (17961716)
Nader Tanideh (10439793)
Kulyash R. Zhilisbayeva (17961731)
Ramazon Safarzoda Sharoffidin (22629836)
Roza Suleimenova (22518749)
Gulden Yelgondina (22518752)
Akmeiir E. Kaliyeva (22679270)
Aigerim A. Umbetova (17961734)
Ainur Zinaliyeva (22679273)
Amin Tamadon (6313595)
dc.date.none.fl_str_mv 2025-11-25T06:24:45Z
dc.identifier.none.fl_str_mv 10.3389/fcell.2025.1699693.s001
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Table_1_In-silico_pharmacological_insights_into_the_therapeutic_potential_of_microRNAs_for_microplastic-associated_cancers_docx/30704027
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cell Biology
microplastics
microRNAs
cancer
therapy resistance
in silico
RNAhybrid
dc.title.none.fl_str_mv Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Microplastics (MPs) are increasingly implicated in cancer biology through effects on gene expression, stress responses, and treatment susceptibility; however, causal links remain provisional. We systematically screened PubMed and Google Scholar (through September 2025) to identify cancer-related genes reported to be altered by MP exposure and then evaluated microRNAs (miRNAs) with anticancer activity that may target those genes. Mature miRNA sequences were retrieved from RNAcentral and assessed against MP-altered genes using RNAhybrid for target-site prediction and minimum free-energy (mfe) hybridization. MPs were reported to modulate genes across multiple tumor types—including breast, gastric, liver, lung, colorectal, cervical, pancreatic, and skin. In silico analyses identified candidate miRNAs with favorable mfe values for these targets, including miR-483-3p, miR-365, miR-331-3p, miR-138-5p, miR-760, miR-1-3p, miR-665, miR-490-3p, miR-370-3p, miR-520a, miR-638, miR-559, miR-532-3p, miR-593-5p, and miR-29b. These interactions suggest putative avenues to counter MP-associated oncogenic programs and therapy resistance. Because mfe predictions do not establish functional regulation, all findings should be interpreted as hypothesis-generating. Priorities for validation include reporter assays, gene/protein modulation, phenotypic rescue, and in vivo testing in MP-exposed models. Collectively, our results nominate miRNAs as candidate tools to interrogate and potentially mitigate MP-associated carcinogenic mechanisms.</p>
eu_rights_str_mv openAccess
id Manara_80e138c99b0f879f8517ada4c9f4838c
identifier_str_mv 10.3389/fcell.2025.1699693.s001
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30704027
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docxAkmaral Baspakova (17961710)Afshin Zare (18096433)Nadiar M. Mussin (17961716)Nader Tanideh (10439793)Kulyash R. Zhilisbayeva (17961731)Ramazon Safarzoda Sharoffidin (22629836)Roza Suleimenova (22518749)Gulden Yelgondina (22518752)Akmeiir E. Kaliyeva (22679270)Aigerim A. Umbetova (17961734)Ainur Zinaliyeva (22679273)Amin Tamadon (6313595)Cell BiologymicroplasticsmicroRNAscancertherapy resistancein silicoRNAhybrid<p>Microplastics (MPs) are increasingly implicated in cancer biology through effects on gene expression, stress responses, and treatment susceptibility; however, causal links remain provisional. We systematically screened PubMed and Google Scholar (through September 2025) to identify cancer-related genes reported to be altered by MP exposure and then evaluated microRNAs (miRNAs) with anticancer activity that may target those genes. Mature miRNA sequences were retrieved from RNAcentral and assessed against MP-altered genes using RNAhybrid for target-site prediction and minimum free-energy (mfe) hybridization. MPs were reported to modulate genes across multiple tumor types—including breast, gastric, liver, lung, colorectal, cervical, pancreatic, and skin. In silico analyses identified candidate miRNAs with favorable mfe values for these targets, including miR-483-3p, miR-365, miR-331-3p, miR-138-5p, miR-760, miR-1-3p, miR-665, miR-490-3p, miR-370-3p, miR-520a, miR-638, miR-559, miR-532-3p, miR-593-5p, and miR-29b. These interactions suggest putative avenues to counter MP-associated oncogenic programs and therapy resistance. Because mfe predictions do not establish functional regulation, all findings should be interpreted as hypothesis-generating. Priorities for validation include reporter assays, gene/protein modulation, phenotypic rescue, and in vivo testing in MP-exposed models. Collectively, our results nominate miRNAs as candidate tools to interrogate and potentially mitigate MP-associated carcinogenic mechanisms.</p>2025-11-25T06:24:45ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.3389/fcell.2025.1699693.s001https://figshare.com/articles/dataset/Table_1_In-silico_pharmacological_insights_into_the_therapeutic_potential_of_microRNAs_for_microplastic-associated_cancers_docx/30704027CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307040272025-11-25T06:24:45Z
spellingShingle Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
Akmaral Baspakova (17961710)
Cell Biology
microplastics
microRNAs
cancer
therapy resistance
in silico
RNAhybrid
status_str publishedVersion
title Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
title_full Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
title_fullStr Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
title_full_unstemmed Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
title_short Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
title_sort Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
topic Cell Biology
microplastics
microRNAs
cancer
therapy resistance
in silico
RNAhybrid